Alpha-Lactalbumin Vaccine May be ‘Exciting’ Option for Preventing/Treating TNBC
December 9th 2023More funding is necessary for additional trials investigating the potential clinical benefit of an alpha-lactalbumin vaccine for patients with high-risk operable triple-negative breast cancer and those at high risk of developing the disease, says G. Thomas Budd, MD.